Outcomes in patients with peripheral vascular disease following percutaneous coronary intervention

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
John RamzyMelbourne Interventional Group (MIG)

Abstract

To evaluate the clinical characteristics and outcomes of patients with peripheral vascular disease (PVD) undergoing percutaneous coronary intervention (PCI) in a contemporary setting, and to determine whether use of drug-eluting stents (DESs) improves outcomes. PVD was an independent risk factor for adverse outcomes following PCI in the bare-metal stent (BMS) era. It is not known whether outcomes in these patients have improved with advances in interventional techniques and stent technology, as they have for the general population. Eighteen thousand three hundred and eighty patients undergoing PCI from an Australian registry between 2005 and 2013 were studied. Clinical and procedural data, 30-day and 12-month outcomes were compared in those with and without a reported history of PVD. Outcomes were also compared between patients with PVD who received DES and those who received BMS. Long-term mortality was compared using Australian National Death Index (NDI) linkage. Patients with PVD (n = 1,251, 6.8%) were older and had more prevalent diabetes, hypertension, cerebrovascular disease, heart failure, renal impairment, ostial lesions, left main, and multi-vessel disease (p < 0.001). Patients with PVD had significantly higher rates o...Continue Reading

References

Sep 15, 2000·Journal of the American College of Cardiology·M SinghD R Holmes
Sep 19, 2001·JAMA : the Journal of the American Medical Association·A T HirschW R Hiatt
Aug 29, 2003·The American Journal of Cardiology·John H ChiuDavid J Moliterno
Jan 30, 2004·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Eugenia NikolskyMartin B Leon
Feb 27, 2004·The Medical Journal of Australia·Stephen E GravesNicole L Pratt
Jul 5, 2005·Blood·David A LaneJames A Huntington
Feb 14, 2006·Heart, Lung & Circulation·A E AjaniUNKNOWN Melbourne Interventional Group investigators
Oct 4, 2006·The Medical Journal of Australia·Bryan P YanDavid J Clark
Feb 14, 2007·The New England Journal of Medicine·Bo LagerqvistUNKNOWN SCAAR Study Group
Apr 11, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Leonid YatskarJames Slater
Mar 6, 2010·The Medical Journal of Australia·John J McNeilPeter A Cameron
Feb 1, 2011·Heart, Lung & Circulation·Nick AndrianopoulosChristopher M Reid
Sep 17, 2011·The American Journal of Cardiology·William McLeish WilsonAndrew Edward Ajani
Mar 14, 2013·JAMA : the Journal of the American Medical Association·Adnan K ChhatriwallaUNKNOWN National Cardiovascular Data Registry
Apr 30, 2013·Atherosclerosis·Yuko MorikamiUNKNOWN CREDO-Kyoto PCI/CABG registry cohort-2 investigators

❮ Previous
Next ❯

Citations

Dec 8, 2020·Journal of the American Heart Association·Leor PerlRan Kornowski
Feb 25, 2021·SAGE Open Medicine·Sakiru Oyetunji IsaLuis Afonso
Apr 30, 2021·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Aaron N DunnStephen G Ellis
Oct 19, 2020·JACC. Cardiovascular Interventions·Laurent FarouxJosep Rodés-Cabau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved